Browsing by Author Papavasiliou, E. C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 14 of 14
TitleAuthor(s)Issue date
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled studyGeorgiadis, A. N.; Papavasiliou, E. C.; Lourida, E. S.; Alamanos, Y.; Kostara, C.; Tselepis, A. D.; Drosos, A. A.24-Nov-2015
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled studyGeorgiadis, A. N.; Papavasiliou, E. C.; Lourida, E. S.; Alamanos, Y.; Kostara, C.; Tselepis, A. D.; Drosos, A. A.24-Nov-2015
Effects of eprosartan on serum metabolic parameters in patients with essential hypertensionRizos, E. C.; Spyrou, A.; Liberopoulos, E. N.; Papavasiliou, E. C.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndromeFilippatos, T. D.; Liberopoulos, E. N.; Kostapanos, M.; Gazi, I. F.; Papavasiliou, E. C.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Epoetin alpha increases plasma HDL levels and HDL-associated PAF-acetylhydrolase activity in patients with chronic renal failurePapavasiliou, E. C.; Gouva, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015
Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: Effect of long-term therapy with erythropoietinPapavasiliou, E. C.; Gouva, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015
Erythropoietin administration in patients with chronic renal failure prevents the decrease in RBC-associated antioxidant enzyme activitiesPapavasiliou, E. C.; Gouva, C.; Katopodis, K. P.; Nikolopoulos, P.; Tselepis, A. D.; Siamopoulos, K. C.24-Nov-2015
High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuriaTentolouris, N.; Stylianou, A.; Lourida, E.; Perrea, D.; Kyriaki, D.; Papavasiliou, E. C.; Tselepis, A. D.; Katsilambros, N.24-Nov-2015
Long-term treatment with EPO increases serum levels of high-density lipoprotein in patients with CKDSiamopoulos, K. C.; Gouva, C.; Katopodis, K. P.; Tzallas, C.; Nikolopoulos, P.; Papavasiliou, E. C.; Tselepis, A. D.24-Nov-2015
PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietinPapavasiliou, E. C.; Gouva, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A(2)Lourida, E. S.; Georgiadis, A. N.; Papavasiliou, E. C.; Papathanasiou, A. I.; Drosos, A. A.; Tselepis, A. D.24-Nov-2015
Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with beta-thalassemiaTselepis, A. D.; Hahalis, G.; Tellis, C. C.; Papavasiliou, E. C.; Mylona, P. T.; Kourakli, A.; Alexopoulos, D. C.24-Nov-2015
Platelet derived microparticles inhibit Cu2+-induced LDL oxidationMitsios, J. V.; Lourida, E. S.; Papavasiliou, E. C.; Tselepis, A. D.24-Nov-2015
Production and secretion of the lipoprotein-associated phospholipase A2 (LpPLA2) from blood monocytes of patients with early rheumatoid arthritis: Effect of disease modifying antirheumatic drugs administrationPapavasiliou, E. C.; Georgiadis, A. N.; Drosos, A. A.; Tselepis, A. D.24-Nov-2015